StockOtters
StockOttersSupply Chain Map
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. logo

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

2196.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
5,339
Cost of Revenue
2,778
Gross Profit
2,561
Gross Margin
48.0%
Operating Income
552
Operating Margin
10.3%
Net Income
360
Net Margin
6.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,118
EBITDA Margin
20.9%

2023

12/31/2023

Revenue
5,382
Cost of Revenue
2,823
Gross Profit
2,559
Gross Margin
47.5%
Operating Income
430
Operating Margin
8.0%
Net Income
310
Net Margin
5.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
982
EBITDA Margin
18.2%

2022

12/31/2022

Revenue
5,714
Cost of Revenue
3,012
Gross Profit
2,702
Gross Margin
47.3%
Operating Income
1,079
Operating Margin
18.9%
Net Income
485
Net Margin
8.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,024
EBITDA Margin
17.9%

2021

12/31/2021

Revenue
5,071
Cost of Revenue
2,630
Gross Profit
2,441
Gross Margin
48.1%
Operating Income
821
Operating Margin
16.2%
Net Income
615
Net Margin
12.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,131
EBITDA Margin
22.3%

2020

12/31/2020

Revenue
3,940
Cost of Revenue
1,746
Gross Profit
2,194
Gross Margin
55.7%
Operating Income
614
Operating Margin
15.6%
Net Income
476
Net Margin
12.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
939
EBITDA Margin
23.8%